CurveBeam AI Limited (ASX:CVB)
Australia · Delayed Price · Currency is AUD 0.0320
+0.0070 (28.00%)
At close: Sep 17, 2026
CurveBeam AI Revenue
In the fiscal year ending June 30, 2026, CurveBeam AI had annual revenue of 8.67M AUD, down -28.36%. CurveBeam AI had revenue of 3.70M in the half year ending June 30, 2026, with 23.53% growth.
Revenue
8.67M
Revenue Growth
-28.36%
P/S Ratio
2.83
Revenue / Employee
173.32K
Employees
50
Market Cap
24.56M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 8.67M | -3.43M | -28.36% |
| Jun 30, 2025 | 12.10M | 5.57M | 85.33% |
| Jun 30, 2024 | 6.53M | -1.53M | -18.97% |
| Jun 30, 2023 | 8.06M | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 34.87M |
| CleanSpace Holdings | 19.82M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| CONNEQT Health | 7.96M |
| Atomo Diagnostics | 5.33M |
| OncoSil Medical | 5.09M |
| Control Bionics | 4.77M |